Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

GMP Audit Findings

SOPs Lack Audit Trail Review Frequency: A Data Integrity Risk

Posted on By

SOPs Lack Audit Trail Review Frequency: A Data Integrity Risk GMP SOPs Missing Audit Trail Review Frequency: A Risk to Data Integrity Introduction to the Audit Finding 1. SOPs Don’t Specify Review Intervals Key SOPs for electronic systems often omit defined frequency for reviewing audit trails. 2. Regulatory Risk Exposure Without routine reviews, critical changes,…

Read More “SOPs Lack Audit Trail Review Frequency: A Data Integrity Risk” »

Data Integrity Gaps, GMP Audit Findings

No SOP for Electronic Record Review in QC Systems: A Data Integrity Violation

Posted on By

No SOP for Electronic Record Review in QC Systems: A Data Integrity Violation Missing SOP for QC Electronic Data Review: A Critical Regulatory Lapse Introduction to the Audit Finding 1. SOPs Missing for LIMS and QC Systems Many labs operate systems like LIMS, CDS, or ELN without SOPs guiding data review protocols. 2. Impact on…

Read More “No SOP for Electronic Record Review in QC Systems: A Data Integrity Violation” »

Data Integrity Gaps, GMP Audit Findings

Failure to Define Backup and Archival SOPs: A Data Integrity Concern

Posted on By

Failure to Define Backup and Archival SOPs: A Data Integrity Concern GMP Risk: Missing SOPs for Data Backup and Archival Procedures Introduction to the Audit Finding 1. No SOP for Data Backup In several GMP facilities, backup procedures for electronic records are either undocumented or loosely defined. 2. Archival Process Ambiguity Critical GMP records are…

Read More “Failure to Define Backup and Archival SOPs: A Data Integrity Concern” »

Data Integrity Gaps, GMP Audit Findings

No Access Control SOPs for GMP Systems: A Critical Data Integrity Gap

Posted on By

No Access Control SOPs for GMP Systems: A Critical Data Integrity Gap Missing Access Control Procedures for GMP Systems: A Risk to Data Integrity Introduction to the Audit Finding 1. No SOP for Access Rights GMP systems like LIMS, MES, or ERP lack written procedures to manage user access. 2. Role-Based Access Undefined There’s no…

Read More “No Access Control SOPs for GMP Systems: A Critical Data Integrity Gap” »

Data Integrity Gaps, GMP Audit Findings

SOP Gaps in Data Correction Documentation: Risk to GMP Integrity

Posted on By

SOP Gaps in Data Correction Documentation: Risk to GMP Integrity GMP Risk: SOP Lacks Guidelines for Documenting Data Corrections Introduction to the Audit Finding 1. SOP Omits Correction Protocols Key GMP records are corrected without following any defined method or procedure. 2. No Consistency in Corrections Corrections vary between operators—some overwrite, others use white-out or…

Read More “SOP Gaps in Data Correction Documentation: Risk to GMP Integrity” »

Data Integrity Gaps, GMP Audit Findings

When SOPs Say One Thing and Operators Do Another: A Compliance Breakdown

Posted on By

When SOPs Say One Thing and Operators Do Another: A Compliance Breakdown Mismatch Between SOPs and Actual Practice: A Hidden GMP Risk Introduction to the Audit Finding 1. SOPs Not Followed Operators consistently perform tasks differently from what’s documented in the SOPs. 2. Informal Methods Emerge Unofficial workarounds and tribal knowledge override approved instructions. 3….

Read More “When SOPs Say One Thing and Operators Do Another: A Compliance Breakdown” »

GMP Audit Findings, Mismatch Between SOPs and Practice

Audit Risk: Logbooks Reflect Actions Not Found in SOPs

Posted on By

Audit Risk: Logbooks Reflect Actions Not Found in SOPs When Manufacturing Logbooks Go Off-Script: SOP Discrepancies in Practice Introduction to the Audit Finding 1. Unrecorded SOP References Manufacturing logbooks include procedures that do not exist in any approved SOPs. 2. Conflicts in Documentation Operators perform tasks and record them, but the activities are unsupported by…

Read More “Audit Risk: Logbooks Reflect Actions Not Found in SOPs” »

GMP Audit Findings, Mismatch Between SOPs and Practice

QC Analysts Using Unapproved Test Methods: A Critical SOP Compliance Risk

Posted on By

QC Analysts Using Unapproved Test Methods: A Critical SOP Compliance Risk Unauthorized Testing Methods in QC Labs: When Practice Strays From SOPs Introduction to the Audit Finding 1. QC Analysts Deviating from SOPs QC analysts use unapproved or alternate test methods not described in the validated SOPs. 2. Informal Practice Becomes Routine Such deviations are…

Read More “QC Analysts Using Unapproved Test Methods: A Critical SOP Compliance Risk” »

GMP Audit Findings, Mismatch Between SOPs and Practice

Unlogged Cleaning Deviations in Batch Records: A GMP Compliance Risk

Posted on By

Unlogged Cleaning Deviations in Batch Records: A GMP Compliance Risk Cleaning Deviations in Batch Records Without Deviation Logging: A Recipe for GMP Trouble Introduction to the Audit Finding 1. Discrepancies in Batch Records Cleaning steps recorded in batch records differ from those described in the approved SOPs. 2. Missing Deviation Reports No deviations were raised…

Read More “Unlogged Cleaning Deviations in Batch Records: A GMP Compliance Risk” »

GMP Audit Findings, Mismatch Between SOPs and Practice

Operator Interview Contradictions During Audits: A GMP Compliance Red Flag

Posted on By

Operator Interview Contradictions During Audits: A GMP Compliance Red Flag When Operator Statements Don’t Match SOPs: A Hidden Threat to GMP Compliance Introduction to the Audit Finding 1. SOP vs Practice Discrepancies During regulatory inspections, operators often describe process steps that differ from those documented in SOPs. 2. Red Flag in Audit Interviews Such discrepancies…

Read More “Operator Interview Contradictions During Audits: A GMP Compliance Red Flag” »

GMP Audit Findings, Mismatch Between SOPs and Practice

Posts pagination

Previous 1 … 4 5 6 … 12 Next

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme